ArticleFrontiers in immunology2025

Induction chemoimmunotherapy may achieve non-inferior outcomes to consolidation immunotherapy in patients with unresectable stage III NSCLC: a real-world multicenter retrospective study.

Song Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.